Vincent Delorme

Institut Pasteur Korea — South Korea

Medicine · Health Sciences

23h-index1.7kcitations49works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(30), Mycobacterium research and diagnosis(10), Biochemical and Molecular Research(10), Cancer therapeutics and mechanisms(6), Pneumocystis jirovecii pneumonia detection and treatment(5)

Publications49 total

Lung epithelial and alveolar macrophage-like cell interactions significantly modify innate responses to bacterial endotoxin with the involvement of direct cellular contacts, TNF-α, ICAM1 and MCP-1
Frontiers in Immunology·2026Open Access
Generation of induced alveolar assembloids with functional alveolar-like macrophages
Nature Communications·2025· 13 citedOpen Access
Identification and characterization of new structural scaffolds modulating the activity of Mycobacterium tuberculosis dihydroneopterin aldolase (FolB) in vitro
Frontiers in Tropical Diseases·2024Open Access
Identification and characterization of new structural scaffolds modulating the activity of <i>Mycobacterium tuberculosis</i> dihydroneopterin aldolase (FolB) <i>in vitro</i>
2023Open Access
<i>Mycobacterium tuberculosis</i> induces delayed lipid droplet accumulation in dendritic cells depending on bacterial viability and virulence
Molecular Microbiology·2022· 7 citedOpen Access
Biolum’ RGB: A Low-Cost, Versatile, and Sensitive Bioluminescence Imaging Instrument for a Broad Range of Users
ACS Sensors·2022· 6 cited
An effective nano drug delivery and combination therapy for the treatment of Tuberculosis
Scientific Reports·2022· 35 citedOpen Access
The small-molecule SMARt751 reverses <i>Mycobacterium tuberculosis</i> resistance to ethionamide in acute and chronic mouse models of tuberculosis
Science Translational Medicine·2022· 27 citedOpen Access
A combination screening to identify enhancers of para-aminosalicylic acid against Mycobacterium tuberculosis
Scientific Reports·2022· 6 citedOpen Access
An effective Nano Drug Delivery and combination therapy for the treatment of Tuberculosis
Research Square (Research Square)·2022· 1 citedOpen Access
PlateEditor: A web-based application for the management of multi-well plate layouts and associated data
PLoS ONE·2021· 4 citedOpen Access
Phenotypic Screening for Drug Discovery in Tuberculosis
2020
Discovery of thienothiazolocarboxamide analogues as novel anti-tubercular agent
Bioorganic & Medicinal Chemistry·2020· 4 citedOpen Access
Self-assembly of a bioinspired, photoactive-centered nanocontainer for drug delivery
2020
Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages
Stem Cell Reports·2019· 47 citedOpen Access
Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis
Bioorganic Chemistry·2018· 31 citedOpen Access
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
Scientific Reports·2018Open Access
Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains
Frontiers in Cellular and Infection Microbiology·2018· 171 citedOpen Access
Mycobacterium tuberculosis Infection and Innate Responses in a New Model of Lung Alveolar Macrophages
Frontiers in Immunology·2018· 54 citedOpen Access
Arf <scp>GAP</scp> 1 restricts <i>Mycobacterium tuberculosis</i> entry by controlling the actin cytoskeleton
EMBO Reports·2017· 20 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Priscille Brodin(21), Alain R. Baulard(13), Ok‐Ryul Song(10), Stéphane Canaan(9), Frédéric Carrière(8), Raffaella Iantomasi(8), Christophe J. Queval(8), Nathalie Deboosère(8), Minjeong Woo(8), Jean‐François Cavalier(7), Samuel Jouny(6), Jinyeong Heo(6), David Shum(6), Virgínia Carla de Almeida Falcão(6), Frédéric Fotiadu(5), Valérie Landry(5), Connor Wood(5), Marion Flipo(4), Benoît Déprez(4), Nicolas Willand(4)